Mechanism for cotolerance in nonlethally conditioned mixed chimeras: Negative selection of the V(β) T-cell receptor repertoire by both host and donor bone marrow-derived cells

Blood

Volumn 88, Issue 12, 1996, Pages 4601-4610

  Colson, Yolonda L ^a   Lange, Jessica ^a   Fowler, Kristin ^a   Ildstad, Suzanne T ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CHIMERA; CLONAL ANERGY; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HOST RESISTANCE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; WHOLE BODY RADIATION;

EID: 0029906953     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4601.bloodjournal88124601     Document Type: Article

References (61)

1. Burnet FM: The Cloual Selection Theory of Acquired Immunity. Cambridge, MA, University Press, 1959
2. + thymocytes. Nature 333:742, 1988
3. β negative selection in an athymic environment. Science 246:1041, 1989
4. Fry A, Jones L, Kruisbeek A, Matis L: Thymic requirement for clonal deletion during T-cell development. Science 246:1044, 1989
5. Ramsdell F, Fowlkes BJ: Clonal deletion versus clonal anergy: The role of the thymus in inducing self tolerance. Science 248:1342, 1990
6. Kappler JW, Roehm N, Marrack PC: T cell tolerance by clonal elimination in the thymus. Cell 49:273, 1987
7. β11 T-cells cosegregate with mammary tumor virus genomes. Nature 349:531, 1990
8. Woodland D, Happ MP, Bill J, Palmer E: Requirement for cotoleragenic gene products in the clonal deletion I-E reactive T-cells. Science 247:964, 1990
9. Woodland DL, Happ MP, Gollup KJ, Palmer E: An endogenous retrovirus mediating deletion of αβ T-cells. Nature 349:529, 1991
10. Fowlkes BJ, Schwartz RH, Pardoll DM: Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage. Nature 334:620, 1988
11. McDonald HR, Hengartner H, Pedrazzini T: Intrathymic deletion of self-reactive cells prevented by neonatal anti-CD4 antibody treatment. Nature 335:174, 1988
12. Tomonari K, Fairchild S, Rosenwasser OA: Influence of viral superantigen on Vβ- and Vα-specific positive and negative selection. Immunol Rev 131:131, 1993
13. Webb S, Morrris C, Sprent J: Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 63:1249, 1990
14. Jones L, Chin L, Longo D, Kruisbeek A: Peripheral clonal elimination of functional T cells. Science 250:1726, 1990
15. Roberts JL, Sharrow SO, Singer A: Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J Exp Med 171:935, 1990
16. Marrack P, Brinster R, Palmiter L, Burkly R, Flavvel RH, Kappler J: The effect of thymus environment on T cell development and tolerance. Cell 53:627, 1988
17. β families is associated with expression of multiple MHC and non-MHC gene products. J Exp Med 170:1335, 1989
18. Alters SE, Song HK, Fathman CG: Evidence that clonal anergy is induced in thymic migrant cells after anti-CD4-mediated transplantation tolerance. Transplantation 56:633, 1993
19. Becker JC, Brabletz T, Kirchner T, Conrad CT, Brocker EB, Reisfeld RA: Negative transcriptional regulation in anergic T cells. Proc Natl Acad Sci USA 92:2375, 1995
20. Van Reijsen FC, Wijburg OL, Gebhardt M, Van leperen-Van Dijk AG, Betz S, Poellabauer EM, Thepan T, Bruijnzeel-Koomen CA, Mudde GC: Different growth factor requirements for human TH2 cells may reflect in vivo induced anergy. Clin Exp Immunol 98:151, 1994
21. Boussiotis VA, Freeman GJ, Griffin JD, Gray GS, Gribben JG, Nadler LM: CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J Exp Med 180:1665, 1994
22. Wolf H, Muller Y, Salmen S, Wilmanns W, Jung G: Induction of anergy in resting human T lymphocytes by immobilized anti-CD3 antibodies. Eur J Immunol 24:1410, 1994
23. Zinkernagel RM, Althage A, Callahan G, Welsh RM: On the immunoincompetence of H-2 incompatible irradiated bone marrow chimeras. J Immunol 124:2356, 1980
24. van Bekkum D, deVries M: Secondary disease following bone marrow transplantation, in Radiation Chimeras. London, UK, Logos, 1967, p 79
25. Rayfield L, Brent L: Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras. Transplantation 36:183, 1983
26. Krown GE, Coico R, Scheid MP, Fernandez G, Good RA: Immune function in fully allogeneic mouse bone marrow chimeras. Clin Immunol Immunopathol 19:268, 1981
27. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH: Characterization of mixed allogeneic chimeras: Immunocompetence, in vitro reactivity and genetic specificity of tolerance. J Exp Med 162:231, 1985
28. Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST: A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor and hematopoietic histocompatibility barriers. J Immunol 155:4179, 1995
29. Cobbold S, Martin G, Qin S, Waldmann H: Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323:164, 1986
30. Sharabi Y, Sachs DH: Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 169:493, 1989
31. Tomita Y, Khan A, Sykes M: Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 153:1087, 1994
32. Eto M, Mayume H, Tomita Y, Yoshikai Y, Nishimura Y, Nomoto K: Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion. J Immunol 145:1303, 1990
33. Tomita Y, Nishimura Y, Harada N, Eto M, Ayukawa K, Yoshikai Y, Nomoto K: Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion. J Immunol 145:4026, 1990
34. Maeda T, Eto M, Nishimura Y, Nomoto K, Kong Y, Nomoto K: Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice. J Exp Med 171:97, 1990
35. Taniguchi H, Abe M, Shirai T, Fukao K, Nakauchi H: Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras. J Immunol 155:5631, 1995
36. Ryan JJ, Leienne HB, Mond JJ, Finkelman FD: Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen. Immunogenetics 34:88, 1991
37. β12 T cell receptors for antigen. J Immunol 147:739, 1991
38. Beutner U, Frankel WN, Cote MS, Coffin JM, Huber BT: Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc Natl Acad Sci USA 89:5432, 1992
39. β11-positive mouse T cell clone. Immunogenetics 28:445, 1988
40. + T cells. Immunogenetics 33:157, 1991
41. a reactive T cells. Nature 335:827, 1988
42. Fry AM, Matis LA: Self-tolerance alters T-cell receptor expression in an antigen-specific MHC restricted immune response. Nature 335:830, 1988
43. Pullen AM, Marrack P, Kappler JW: The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature 335:796, 1988
44. f-reactive T cells. J Immunol 149:3440, 1992
45. Jeffries WE, Green JR, Williams AF: Authentic T-helper CD4 (W3/25) antigen on rat peritoneal macrophages. J Exp Med 117:127, 1985
46. Fukushi N, Wang B, Arase H, Ogasaware K, Good R, Onoe K: Cell components required for deletion of an autoreactive T cell repertoire. Eur J Immunol 20:1153, 1990
47. Bill J, Palner E: Positive selection of CD4+ T cells mediated by MHC class II-bearing stromal cells in the thymic cortex. Nature 341:649, 1989
48. Von Boehmer H, Schubiger K: Thymocytes appear to ignore class I major histocompatibility complex antigens expressed on thymus epithelial cells. Eur J Immunol 14:1048, 1984
49. Ready A, Jenkinson E, Kingston R, Owen J: Successful Iransplantation across major histocompatibility barrier of deoxyguanosine-treated embryonic thymus expressing class II antigens. Nature 310:231, 1984
50. a mice. Implications for T cell development and autoimmunity. J Exp Med 169:2149, 1989
51. Kappler J, Staerz U, White J, Marrack PC: Self-tolerance eliminates T-cells specific for Mis-modified products of the major histocompatibility complex. Nature 332:35, 1988
52. β14 positive T-cells in mammary tumor virus transgenic mice. Nature 350:207, 1991
53. Choi Y, Kappler J, Marrack P: A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumor virus. Nature 350:203, 1991
54. Allen PM: Peptides in positive and negative selection: A delicate balance. Cell 76:593, 1994
55. Ashton-Rickardt PG, Tonegawa S: A differential-avidity model for T cell selection. Immunol Today 15:362, 1994
56. Marrack P, Parker DC: A little of what you fancy. Nature 316:67, 1994
57. Hengartner H, Odermatt B, Schneider R, Schreyer M, Walle O, MacDonald HR, Zinkernagel RM: Deletion of self reactive T cells before entry into the thymus medulla. Nature 336:388, 1988
58. Korngold R, Sprent J: Lethal GVHD after bone marrow transplantation across minor histocompatibility barriers in mice: Prevention by removing mature T cells from marrow. J Exp Med 148:1687, 1978
59. Trentin JJ: Mortality and skin transplantability in X-irradiated mice receiving isologous, homologous and heterologous bone marrow. Proc Soc Exp Biol Med 92:688, 1956
60. Agus D, Surh C, Sprent J: Reentry of T cells to the adult thymus is restricted to activated T cells. J Exp Med 173:1039, 1991
61. Cudkowicz G, Bennett M: Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 134:83, 1971